CoChat

Peroxisome Proliferator-Activated Receptor α Gene Variants Influence Progression of Coronary Atherosclerosis and Risk of Coronary Artery Disease

Flavell, David M., Jamshidi, Yalda, Hawe, Emma, Pineda Torra, Inés, Taskinen, Marja-Riitta, Frick, M. Heikki, Nieminen, Markku S., Kesäniemi, Y. Antero, Pasternack, Amos, Staels, Bart, Miller, George, Humphries, Steve E., Talmud, Philippa J., Syvänne, Mikko · 2002 · Circulation
Cited by 134

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background — Peroxisome proliferator-activated receptor α (PPARα) regulates the expression of genes involved in lipid metabolism and inflammation, making it a candidate gene for atherosclerosis and ischemic heart disease (IHD). Methods and Results — We investigated the association between the leucine 162 to valine (L162V) polymorphism and a G to C transversion in intron 7 of the PPARα gene and progression of atherosclerosis in the Lopid Coronary Angiography Trial (LOCAT), a trial examining the effect of gemfibrozil treatment on progression of atherosclerosis after bypass surgery and on risk of IHD in the second Northwick Park Heart Study (NPHS2), a prospective study of healthy middle-aged men in the United Kingdom. There was no association with plasma lipid concentrations in either study. Both polymorphisms influenced progression of atherosclerosis and risk of IHD. V162 allele carriers had less progression of diffuse atherosclerosis than did L162 allele homozygotes with a similar trend for focal atherosclerosis. Intron 7 C allele carriers had greater progression of atherosclerosis than did G allele homozygotes. The V162 allele attenuated the proatherosclerotic effect of the intron 7 C allele. Homozygotes for the intron 7 C allele had increased risk of IHD, an effect modulated by the L162V polymorphism Conclusions — The PPARα gene affects progression of atherosclerosis and risk of IHD. Absence of association with plasma lipid concentrations suggests that PPARα affects atherosclerotic progression directly in the vessel wall.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000012145.80593.25

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 134

Metadata

Authors
Flavell, D. M., Jamshidi, Y., Hawe, E., Pineda Torra, I., Taskinen, M.-R., Frick, M. H., Nieminen, M. S., Kesäniemi, Y. A., Pasternack, A., Staels, B., Miller, G., Humphries, S. E., Talmud, P. J., & Syvänne, M.
Venue
Circulation
Published
2002-03-26
Volume
105
Issue
12
Pages
1440-1445
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2125161216
Cited by
134
References
7
FWCI
3.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peroxisome Proliferator-Activated Receptor α Gene Variants Influence Progression of Coronary Atherosclerosis and Risk of Coronary Artery Disease. https://app.cochat.ai/papers/10.1161/01.cir.0000012145.80593.25
The paper
Flavell, D. M., Jamshidi, Y., Hawe, E., Pineda Torra, I., Taskinen, M.-R., Frick, M. H., Nieminen, M. S., Kesäniemi, Y. A., Pasternack, A., Staels, B., Miller, G., Humphries, S. E., Talmud, P. J., & Syvänne, M. (2002). Peroxisome Proliferator-Activated Receptor α Gene Variants Influence Progression of Coronary Atherosclerosis and Risk of Coronary Artery Disease. Circulation. https://doi.org/10.1161/01.cir.0000012145.80593.25

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.